If You Take the Pill, Two GLP-1s Tell You to Change Method — and Six Do Not

If you take an oral contraceptive and you are starting a GLP-1, which drug you were prescribed changes what you are supposed to do about it. Two of them tell you to change method. The rest say nothing on the subject at all.

Mounjaro, label revised 6 May 2026:

"Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 4 weeks after initiation and for 4 weeks after each dose escalation with MOUNJARO."

Zepbound, revised 6 May 2026, says the same thing with its own name. Both are tirzepatide.

Read "each dose escalation" again

Titration on tirzepatide moves roughly every four weeks through the early months. So "four weeks after initiation and four weeks after each dose escalation" is not a one-off precaution at the start — for anyone climbing through the dose steps, it covers most of that climb, with the windows running back to back.

That is a materially different instruction from "be careful for the first month", and it is the part most likely to be lost when this reaches a patient as a paraphrase.

Which labels carry it, checked rather than assumed

I searched all ten labels in the corpus for the instruction. Two carry it:

• Mounjaro — yes
• Zepbound — yes
• Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Trulicity, Byetta, Bydureon BCise — no

Trulicity is the one worth pausing on. Same manufacturer as Mounjaro and Zepbound, same weekly injection, and it does not carry the instruction. So this is a property of tirzepatide, not of Eli Lilly and not of the GLP-1 class.

The mechanism is delayed gastric emptying, which is also why the effect is tied to starting and to dose increases rather than being permanent: the delay is largest when the dose changes and attenuates as the body adjusts.

Byetta words it differently, and the difference matters

The Byetta label, revised 8 September 2025, does not mention contraception as a method question. It gives a timing instruction instead:

"For oral medications that are dependent on threshold concentrations for efficacy, such as contraceptives and antibiotics, patients should be advised to take those drugs at least 1 hour before BYETTA injection."

Same underlying concern — an oral drug that needs to reach a threshold concentration — with a completely different answer. Byetta says separate them in time. Tirzepatide says change the method for a defined window. Neither instruction transfers to the other drug.

What the absence does and does not mean

Six labels not carrying the instruction is not the same as six labels saying "no interaction". It means their manufacturers did not include one, and the reasons are not stated. Ozempic and the other semaglutide products delay gastric emptying too.

What you can take from the absence is narrower and more useful: if your prescriber is working from the label, the advice you get will differ by drug, and if you switch products the instruction does not travel with you.

What to do with this

Say which drug you are on, not which class. "I am on a GLP-1" does not answer this question. "I am starting Zepbound" does.

Ask specifically about the escalation windows, not just the start. The four weeks after each increase is the part that is easy to drop.

If you switch between GLP-1s, ask again. The instruction is specific to tirzepatide and does not carry over in either direction.

Check the revision date. Both tirzepatide labels quoted here are May 2026. Contraception language in this class has changed as data accumulated, and an article written before that revision describes something else.

Where this comes from

Every quotation is from the manufacturer's Structured Product Label as published on DailyMed, the National Library of Medicine's repository. The which-labels-carry-it check was run across all ten labels in our corpus rather than inferred from the two that do — an absence claim is worth nothing unless you looked.

This is information, not medical advice. Contraception is a decision for you and your prescriber; what the labels give you is the specific question, and the reason it differs by drug.